Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

richard-vellacott

Horizon Discovery appoints chief financial officer

August 7, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Horizon Discovery, Richard Vellacott

Horizon Discovery has announced the appointment of Richard Vellacott as chief financial officer. The firm which is a provider of …
Appointment
Pfizer image

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012 Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …
News

Novartis and Pennsylvania team up on cancer research

August 6, 2012 Research and Development Cancer, Novartis, University of Pennsylvania, chimeric antigen receptor

Novartis and the University of Pennsylvania have joined forces to investigate a method of treating cancer which encourages patients’ immune …
News
ian_broadway

Talentmark appoints director of Managed Services

August 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ian Broadway, Talentmark

Life sciences recruitment firm Talentmark has appointed Ian Broadway as director of Managed Services. Broadway is an experienced life science …
Appointment

Government healthcare fund pays up

August 3, 2012 Research and Development, Sales and Marketing ABPI, MRC, SMEs, government

A £180 million government fund to help small businesses and academics come up with healthcare solutions has made its first …
News
dr

Teva makes two senior executive appointments

August 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Aharon (Arik) Yaari, Carlo De Notaristefani, Teva

Teva has announced the appointments of Dr Carlo De Notaristefani as president and chief executive of Global Operations, and Aharon …
Appointment
Pfizer Sandwich image

Pfizer Sandwich site sold to private consortium

August 3, 2012 Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
News

Bristol-Myers Squibb halts Hep C pill study

August 2, 2012 Research and Development, Sales and Marketing BMS, hepatitis C, pill, trial suspension

Bristol-Myers Squibb has halted a mid-stage trial of a new Hepatitis C drug due to major safety concerns. In a …
News
Daiichi Sankyo UK

Daiichi Sankyo: breaking down barriers with social media

August 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media

Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …
Feature

Olympics to kick-start research ventures

August 1, 2012 Research and Development, Sales and Marketing GSK, London 2012, Olympics, research

London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …
News

MRN posts 533% growth in first five years

August 1, 2012 Research and Development clinical trials, growth, results

From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …
News
Press release

Pfizer’s RA pill impresses in Phase III

August 1, 2012 Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …
News

Ariad files new blood cancer drug with the FDA

July 31, 2012 Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …
News
tulstrup

Soren Tulstrup to lead Shire’s genetics franchise

July 31, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …
Appointment

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012 Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026